{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
| image = Tigestol structure.svg
| width =

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 896-71-9
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 13471
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 12892
| UNII = 1WAE0P123G
| ChEMBL = 2105440
| KEGG = D06145

<!--Chemical data-->
| C=20 | H=28 | O=1
| molecular_weight = 284.43572 g/mol
| smiles = CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCCC4
| StdInChI_Ref = 
| StdInChI = InChI=1S/C20H28O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h1,16-18,21H,4-13H2,2H3/t16-,17-,18+,19+,20+/m1/s1
| StdInChIKey_Ref = 
| StdInChIKey = DHOKBGHAEUVRMO-SLHNCBLASA-N
| synonyms = 
}}

'''Tigestol''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]), also known as '''17α-ethynylestr-5(10)-en-17β-ol''',<ref name="ListHörhammer2013">{{cite book|author1=Paul Heinz List|author2=Ludwig Hörhammer|title=Chemikalien und Drogen Teil C: T–Z|url=https://books.google.com/books?id=t4qfBgAAQBAJ&pg=PA179|date=12 March 2013|publisher=Springer-Verlag|isbn=978-3-642-67085-5|pages=179–}}</ref> is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group that was developed by [[Organon International|Organon]] in the 1960s but was never marketed.<ref name="HillMakin1991">{{cite book|author1=R.A. Hill|author2=H.L.J. Makin|author3=D.N. Kirk|author4=G.M. Murphy|title=Dictionary of Steroids|url=https://books.google.com/books?id=AI7EnUyeEtUC&pg=PA424|date=23 May 1991|publisher=CRC Press|isbn=978-0-412-27060-4|pages=424–}}</ref><ref>{{cite book|title=United States Adopted Names (USAN).|url=https://books.google.com/books?id=1-dsAAAAMAAJ|year=1969|publisher=United States Pharmacopeial Convention.|page=65,85}}</ref><ref name="LednicerMitscher1980">{{cite book|author1=Daniel Lednicer|author2=Lester A. Mitscher|title=The Organic Chemistry of Drug Synthesis|url=https://books.google.com/books?id=r-eqWrMoO18C&pg=PA145|date=13 May 1980|publisher=John Wiley & Sons|isbn=978-0-471-04392-8|pages=145–}}</ref><ref name="Lednicer1998">{{cite book|author=Daniel Lednicer|title=Strategies for Organic Drug Synthesis and Design|url=https://books.google.com/books?id=e7zwAAAAMAAJ|year=1998|publisher=Wiley|isbn=978-0-471-19657-0|page=95}}</ref> It is an [[isomer]] of the related 19-nortestosterone derivative progestins [[lynestrenol]] and [[cingestol]].<ref name="GB841411">{{Cite patent|GB|841411}}</ref>

==References==
{{Reflist|2}}


{{Progesterone receptor modulators}}

[[Category:Estranes]]
[[Category:Progestogens]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}